Johnson & Johnson (JNJ)

5 Dividend Aristocrats Boomers Should Own for Life

Founders Financial Alliance LLC Has $4.25 Million Stock Position in Johnson & Johnson $JNJ

GraniteShares Advisors LLC Makes New Investment in Johnson & Johnson $JNJ

Golden Reserve Retirement LLC Has $1.72 Million Position in Johnson & Johnson $JNJ

How to Build $7,800 a Month in Dividend Income Without Owning a Single Yield Trap

FDA approves IMAAVY® (nipocalimab-aahu) as first-ever treatment for warm autoimmune hemolytic anemia (wAIHA), representing a landmark advancement for patients

US FDA expands approval for J&J's drug for rare blood disorder

Q2 Earnings Season Winds Down: 3 Companies That Broke Records

How to Build $3,100 a Month in Dividend Income Starting From Zero

Johnson & Johnson Rises 1.3% as Investors Seek Stability

Louisiana Jury Issues $10 Million Verdict in Talc-Related Mesothelioma Case Against Johnson & Johnson

J&J's Strong Pipeline Momentum Offers Multiple Growth Catalysts Ahead

Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?

How to Build $6,600 a Month in Dividend Income From Three Income Buckets

How to Build $11,800 a Month in Dividend Income Without Selling a Single Share

The Portfolio Blueprint for Building $19,000 a Month in Dividend Income

Bryn Mawr Trust Advisors LLC Acquires 3,209 Shares of Johnson & Johnson $JNJ

Johnson & Johnson: Buy IMAAVY Label Expansion First And Continued CAPLYTA Sales Push

How a 53-Year-Old Can Turn $465,000 Into a Monthly Paycheck Machine by 63

3 Dividend Stocks to Buy and Hold for the Next 5 Years